- Home
- IFRX vs MODD Comparison
IFRX vs MODD Comparison
Compare IFRX & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- MODD
- Stock Information
- Founded
- IFRX 2007
- MODD 1998
- Country
- IFRX Germany
- MODD United States
- Employees
- IFRX N/A
- MODD N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- MODD Industrial Specialties
- Sector
- IFRX Health Care
- MODD Health Care
- Exchange
- IFRX Nasdaq
- MODD Nasdaq
- Market Cap
- IFRX 53.5M
- MODD 46.3M
- IPO Year
- IFRX 2017
- MODD N/A
- Fundamental
- Price
- IFRX $0.85
- MODD $0.70
- Analyst Decision
- IFRX Strong Buy
- MODD
- Analyst Count
- IFRX 4
- MODD 0
- Target Price
- IFRX $7.75
- MODD N/A
- AVG Volume (30 Days)
- IFRX 371.5K
- MODD 191.6K
- Earning Date
- IFRX 08-07-2025
- MODD 08-13-2025
- Dividend Yield
- IFRX N/A
- MODD N/A
- EPS Growth
- IFRX N/A
- MODD N/A
- EPS
- IFRX N/A
- MODD N/A
- Revenue
- IFRX $140,242.00
- MODD N/A
- Revenue This Year
- IFRX N/A
- MODD N/A
- Revenue Next Year
- IFRX $6,309.47
- MODD N/A
- P/E Ratio
- IFRX N/A
- MODD N/A
- Revenue Growth
- IFRX 30.90
- MODD N/A
- 52 Week Low
- IFRX $0.71
- MODD $0.63
- 52 Week High
- IFRX $2.82
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- IFRX 45.30
- MODD 41.75
- Support Level
- IFRX $0.78
- MODD $0.69
- Resistance Level
- IFRX $0.93
- MODD $0.79
- Average True Range (ATR)
- IFRX 0.05
- MODD 0.08
- MACD
- IFRX 0.03
- MODD 0.00
- Stochastic Oscillator
- IFRX 42.32
- MODD 38.42
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.